Skip to content

Live Events
Sign Up / Login

Live Events
Sign Up / Login

Plus Library

By pinki@katapult.biz / February 13, 2025

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 951 - 975 of 2,875

«
1
…
37
38
39
40
41
…
115
»

How I Treat Acute Myeloid Leukemia

How I Treat Acute Myeloid Leukemia

Brian A Jonas - MD - PhD - FACP

Supportive Care in Oncology: Anemia, Neutropenia, Emesis, & Bone Metastases

Supportive Care in Oncology: Anemia, Neutropenia, Emesis, & Bone Metastases

Diana Hernandez, Pharm.D, BS

CAR-T Cell in Oncology

CAR-T Cell in Oncology

Eduardo M. Sotomayor, MD

B-Cell NHL and Hodgkin’s Disease

B-Cell NHL and Hodgkin’s Disease

Eduardo Sotomayor - MD

Acute Lymphoblastic Leukemia: Latest Advances

Acute Lymphoblastic Leukemia: Latest Advances

Gabriel N Mannis - MD

AML: Current Status and Future Directions

AML: Current Status and Future Directions

George Yaghmour, MD, FACP

Acute Myeloid and Lymphoid Leukemias

Acute Myeloid and Lymphoid Leukemias

Hugo F Fernandes, MD

T-Cell Lymphomas: New Therapeutic Approaches

T-Cell Lymphomas: New Therapeutic Approaches

Jasmine Zain - MD

CLL and CML

Javier Pinilla-Ibarz, MD, PhD

What's New in Hematopoietic Stem Cell Transplantation?

What's New in Hematopoietic Stem Cell Transplantation?

Joseph Tuscano, MD

Acute Myeloid and Lymphoid Leukemias

Acute Myeloid and Lymphoid Leukemias

Kevin Kelley, MD, PhD

Myelodysplastic Syndromes and Acute Myeloid Leukemia

Myelodysplastic Syndromes and Acute Myeloid Leukemia

Kevin Kelly - MD - PhD

AML and MDS: Current Status and Future Directions

AML and MDS: Current Status and Future Directions

Kevin Kelly (USC)

Hematologic Malignancies

Hematologic Malignancies

Kevin Kelly (USC), Leslie Popplewell (COH), Jasmine Zain (COH)

AML and MDS: Beyond 7+3

AML and MDS: Beyond 7+3

Kevin Kelly, MD, PhD

AML and MDS: Beyond 7+3

AML and MDS: Beyond 7+3

Kevin Kelly, MD, PhD

Updates in Stem Cell Transplantation and CAR-T Therapy for Heme Malignancies

Updates in Stem Cell Transplantation and CAR-T Therapy for Heme Malignancies

Krishna Komanduri, MD

Bone Marrow Transplant and CAR T Cell Therapy in Hematology Malignancies

Bone Marrow Transplant and CAR T Cell Therapy in Hematology Malignancies

Krishna V. Komanduri, MD

Bone Marrow Transplant and CAR T Cell Therapy in Hematology Malignancies

Bone Marrow Transplant and CAR T Cell Therapy in Hematology Malignancies

Krishna V. Komanduri, MD

DLBCL: The Latest and Greatest

DLBCL: The Latest and Greatest

Leslie L Popplewell - MD - FACP

Myeloma Treatment: Non-Transplant and Transplant Options

Myeloma Treatment: Non-Transplant and Transplant Options

Marco Ruiz, MD

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

Martin S Tallman - MD

Non-Hodgkin and Hodgkin Lymphomas

Non-Hodgkin and Hodgkin Lymphomas

Mohamed A Kharfan-Dabaja, MD, MBA

Chimeric Antigen Receptor (CAR) T-Cell Therapy: Progress and Challenges

Chimeric Antigen Receptor (CAR) T-Cell Therapy: Progress and Challenges

Mohamed A Kharfan-Dabaja, MD, MBA, FACP

Bone Marrow Transplant and CAR T Cell Therapy in Hematology Malignancies

Bone Marrow Transplant and CAR T Cell Therapy in Hematology Malignancies

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

«
1
…
37
38
39
40
41
…
115
»

Post navigation

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok